It may be hard to believe but there have indeed been medical and scientific patents on cannabis filed with the United States Patent Office since before the early 2000s. All this while the War on Drugs and Cannabis Prohibition continues. Below, we have listed some of the most prominent ones that are publicly available for study and review.
​
US Patent 20150005346 A1, Jan 31, 2017 - Allosteric modulators of CB1 cannabinoid receptors
US Patent 20170001949 A1, Jan 5, 2017 - Novel cannabinoid receptor 2 (cb2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
US Patent 20160376211 A1, Dec 29, 2016 - Cannabinoid derivatives
US Patent 20160374958 A1, Dec 29, 2016 - Anti-microbial composition comprising cannabinoids
US Patent 9526752, Dec 27, 2016 - Composition of cannabinoids, odorous volatile compounds, and emu oil for topical application, and a method for cannabinoid transdermal delivery
US Patent 20160367518 A1, Dec 22, 2016 - Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids
US Patent 20160257654 A1, Sep 8, 2016 - Cannabinoid receptor mediating compounds
US Patent 20160243075 A2, Aug 25, 2016 - Tetrahydrocannabivarin (THCv) for use in the protection of pancreatic islet cells
US Patent 20160243055 A1, Aug 25, 2016 - Cannabidiol For Treatment of Severe and Refractory Graft-Versus-Host Disease
US Patent 20160158299 A1, Jun 9, 2016 - Cannabidiol (CBD) Enriched Alcohol
US Patent 20160136128 A1, May 19, 2016 - The use of phytocannabinoids in the treatment of ovarian carcinoma
US Patent 20160136127 A1, May 19, 2016 - Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of brain tumour
US Patent 9326927, May 3, 2016 - Use of cannabinoid compounds for stimulating melanogenesis
US Patent 20160089349 A1, Mar 31, 2016 - Cb2 Receptor Ligands for the Treatment of Psychiatric Disorders
US Patent 20160067235 A1, Mar 10, 2016 - Antagonists of the Cannabinoid Receptor CB1 for Use in the Treatment of Diseases Associated with Neuronal Dendritic Abnormalities
US Patent 20160058736 A1, Mar 3, 2016 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
US Patent 20160010126 A1, Jan 14, 2016 - Production of cannabinoids in yeast
US Patent 20150342922 A1, Dec 3, 2015 - Cannabinoid formulation for the sedation of a human or animal
US Patent 9133127, Sep 15, 2015 - Cannabinoid Receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
US Patent 9133128, Sep 15, 2015 - Pyrazole derivatives as cannabinoid receptor 1 antagonists
US Patent 9125859, Sep 8, 2015 - Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US Patent 9095563, Aug 4, 2015 - Topical treatments incorporating Cannabis sp. derived botanical drug product
US Patent 9095555, Aug 4, 2015 - Cannabinoid formulations
US Patent 9095554, Aug 4, 2015 - Breeding, production, processing and use of specialty cannabis
US Patent 20150197484 A1, Jul 16, 2015 - Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
US Patent 9066920, Jun 30, 2015 - Use of one or a combination of phyto-cannabinoid in the treatment of epilepsy
US Patent 9066910, Jun 30, 2015 - Methods and compositions of cannabis extracts
US Patent 9062004, Jun 23, 2015 - Cannabinoid-2 agonists
US Patent 9017737, Apr 28, 2015 - Use of cannabinoids in combination with an anti-psychotic medication
US Patent 9006442, Apr 14, 2015 - Cannabinoid receptor modulators
US Patent 9006275, Apr 14, 2015 - Compounds as cannabinoid receptor ligands and uses thereof
US Patent 8980942, Mar 17, 2015 - Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
US Patent 8853252, Oct 7, 2014 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
US Patent 8772541, Jul 8, 2014 - Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
US Patent 8735073, May 27, 2014 - Cannabinoid 2 (CB.sub.2) receptor gene promoter and unique RNA transcripts in B cells and methods of use
US Patent 8673368, Mar 18, 2014 - Cannabinoid-containing plant extracts as neuroprotective agents
US Patent 8648072, Feb 11, 2014 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
US Patent 8642645, Feb 4, 2014 - Pharmaceutical composition comprising Cannabinoids
US Patent 8632825, Jan 21, 2014 - Anti-tumoural effects of cannabinoid combinations
US Patent 8546563, Oct 1, 2013 - Compounds which modulate the CB2 receptor
US Patent 8481085, Jul 9, 2013 - Pharmaceutical compositions comprising cannabigerol
US Patent 8449908, May 28, 2013 - Transdermal delivery of cannabidiol
US Patent Application 20130059018 A1, Mar 7, 2013 - Phytocannabinoids in the treatment of cancer
US Patent 8445034, May 21, 2013 - Systems and methods for producing organic cannabis tincture
US Patent 8337908 B2, Dec 25, 2012 - Plant Extract From Low-THC Cannabis for the Treatment of Disease
US Patent 8236763, Aug 7, 2012 - Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
US Patent 8207230, Jun 26, 2012 - Functional role for cannabinoids in autonomic stability during sleep
US Patent 8119697, Feb 21, 2012 - Anti-nausea and anti-vomiting activity of cannabidiol compounds
US Patent 8106244, Jan 31, 2012 - Process for production of delta-9-tetrahydrocannabinol
US Patent 8084422, Dec 27, 2011 - Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity
US Patent 8058264, Nov 15, 2011 - Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
US Patent 7884133, Feb 8, 2011 - Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
US Patent 7763607, Jul 27, 2010 - Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
US Patent 7749953, Jul 6, 2010 - Methods compositions and articles of manufacture for modulating bone growth
US Patent 7674922, Mar 9, 2010 - Process for production of delta-9-tetrahydrocannabinol
US Patent 7611858, Nov 3, 2009 - Detection of cannabinoid receptor biomarkers and uses therof
US Patent 7595339, Sep 29, 2009 - CB1 Modulator Compounds
US Patent 7285683, Oct 23, 2007 - Bicyclic and tricyclic cannabinoids
US Patent 7183313, Feb 27, 2007 - Keto cannabinoids with therapeutic indications
US Patent 6995187, Feb 7, 2006 - Peripheral cannabinoid receptor (CB2) selective ligands
US Patent 6949582, Sep 27, 2005 - Method of relieving analgesia and reducing inflammation using a cannabinoid delivery topical liniment
US Patent 6939977, Sep 6, 2005 - Analgesic and immunomodulatory cannabinoids
US Patent 6903137, Jun 7, 2005 - Agonists specific for the peripheral cannabinoid receptor
US Patent 6630507 B1, Oct 7, 2003 - Cannabinoids as Antioxidants and Neuroprotectants
US Patent 6566543, May 20, 2003 - 2-arachidonylglycerl (2-AG) an inhibitor of tumor necrosis factor-alpha and neuroprotector of brain in closed head injury
US Patent 6328992 B1, Dec 11, 2001 - Cannabinoid Patch and Method for Cannabis Transdermal Delivery
